ICT-07 (Imcheck Therapeutics)

N/A

Report date: 2025/01/26 17:39:35

Base Information

Drug NameICT-07 (Imcheck Therapeutics)
Drug Alias Namebutyrophilin checkpoint modulator 4 (ImCheck Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionButyrophilins modulators
TargetsButyrophilins
Therapy Area/IndicationsSolid tumoursAutoimmune DiseasesHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImCheck Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesImCheck Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsSolid tumoursAutoimmune DiseasesHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A